Samuel Morris, MD
Family Medicine · Martinsburg, WVNPI 1427092956
Payments from drug & device makers
Across 409 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AstraZeneca$567
- AbbVie$563
- GSK$549
- Pfizer$538
- Astellas Pharma US Inc$372
- plus $3K from 30 others
What the payments were for
- Food & beverage$6,30098%
- Education$1362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 82 | $1,158 |
| AstraZeneca | 28 | $567 |
| AbbVie(2 entities) | 47 | $563 |
| GSK | 39 | $549 |
| Pfizer | 36 | $538 |
| Astellas Pharma US Inc | 15 | $372 |
| Novo Nordisk | 22 | $366 |
| Johnson & Johnson | 25 | $287 |
| Abbott | 16 | $255 |
| Amgen | 12 | $208 |
| Exact Sciences | 6 | $160 |
| Otsuka America Pharmaceutical, Inc. | 9 | $136 |
| Sanofi-aventis U.S. LLC | 7 | $130 |
| E.r. Squibb & Sons, L.L.C. | 7 | $112 |
| Idorsia Pharmaceuticals US Inc | 4 | $85 |
| Bayer | 4 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $75 |
| Novartis | 5 | $74 |
| Agios Pharmaceuticals, Inc. | 4 | $73 |
| Medtronic | 3 | $71 |
| Boehringer Ingelheim | 4 | $71 |
| Amarin Pharma, Inc. | 4 | $62 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Genentech USA, Inc. | 3 | $52 |
| Inspire Medical Systems, Inc. | 2 | $46 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Merck | 2 | $27 |
| Averitas Pharma Inc. | 1 | $26 |
| Vivus LLC | 1 | $20 |
| Eisai Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Boston Scientific | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
How this compares
$6,436 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 589 | $233,366 |
| TrulicityDulaglutide | 145 | $149,502 |
| MounjaroTirzepatide | 95 | $136,534 |
| OzempicSemaglutide | 57 | $94,865 |
| JardianceEmpagliflozin | 200 | $87,633 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $58,021 |
| XareltoRivaroxaban | 138 | $52,695 |
| EntrestoSacubitril/Valsartan | 186 | $44,548 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 54 | $32,953 |
| FarxigaDapagliflozin Propanediol | 83 | $32,113 |
| Tresiba Flextouch U-100Insulin Degludec | 88 | $29,649 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 81 | $24,011 |
| Atorvastatin Calcium | 1,933 | $17,963 |
| RexultiBrexpiprazole | 50 | $16,963 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,439 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $1,158 | $286,036240 claims |
| PfizerEliquis | $538 | $233,366589 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy | $549 | $114,985210 claims |
| Novo NordiskOzempic | $366 | $94,86557 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $71 | $93,491212 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $567 | $57,091172 claims |
| Johnson & JohnsonXarelto | $287 | $52,695138 claims |
| NovartisEntresto | $74 | $44,548186 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $136 | $16,96350 claims |
| AbbVieLinzess | $563 | $11,27220 claims |
| Sanofi-aventis U.S. LLCMultaq | $130 | $10,05151 claims |
| Astellas Pharma US IncMyrbetriq | $372 | $9,73660 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Martinsburg
- Cherry LobatonMartinsburg$19K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.